Top Markets
Coin of the day
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
株式のランク #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
株価
$0.85
最終同期: 2025-01-21
時価総額
$411.40
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Fresh2 Group Limited (FRES)

カテゴリー

Fresh2 Group Limited(FRES)のP/S比率
August 2026 時点のP/S比率 TTM: 1.17
Fresh2 Group Limited の最新の財務報告および株価によると、現在のP/S比率(TTM)は 1.17 です。2021 年末時点でのP/S比率は 0.03 でした。
Fresh2 Group Limited の P/S 比率の履歴(2017 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
2026 (TTM) 1.17 3,795.33%
2022 0.03 -13.80%
2021 0.03 -70.24%
2020 0.10 -73.12%
2019 0.37 -0.30%
2018 0.37 -45.00%
2017 0.68 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差
9.88 745.52%
US
10.30 781.65%
NL
- -
CH
4.98 326.09%
BE
- -
KR